Online Trading
Drawing on insights from the initial phase of the initiative, refinements have been implemented concerning eligibility criteria and the incentive claiming process for applicants. Applicants will have a period of 3 years to establish their manufacturing facilities within any of the 4 Target Segments (TS) namely medical consumables, disposables and implants (TS 1), Critical components (TS2), high-end medical devices currently in the early stages of domestic production (TS3), and high-end medical devices presently only assembled within the country (TS4). The incentive rate will taper.
5% for TS1,
TS2 & TS3 saw a 9% increase, and TS4 registered a 6% gain. Within the Consumables and Disposables segment, efforts will center on establishing manufacturing scale and world-class quality. For TS 3 & 4, emphasis will be placed on value chain integration to enhance overall competitiveness and the quality of Made in India devices. The focus on critical component manufacturing under the Scheme is intended to facilitate value chain integration and provide a stimulus to the MSME sector.
The Scheme’s minimum sales threshold for incentive eligibility has been eliminated, and the minimum investment requirement has been reduced. To improve Ease of Doing Business (EoDB), the scheme guidelines have been streamlined and made more investor-friendly. Applicants may now submit an unlimited number of applications across one or more TS, and the application window will remain continuously open for an extended duration.
*9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
*On an average, loss makers registered net trading loss close to ₹ 50,000.
*Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
*Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
a.Register on SCORES Portal (SEBI)
b.Mandatory details for filing complaints on SCORES:
i.Name, PAN, Address, Mobile Number, E-mail ID
c.Benefits:
i.Effective Communication
ii.Speedy redressal of the grievances